NCT00290017 2007-06-08Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyPoint TherapeuticsPhase 3 Terminated400 enrolled